5AM VENTURE MANAGEMENT LLC
Q3 2026 Form 13-F
SAN FRANCISCO, CALIFORNIA
CIK 0001799883
· CRD 160395
· SEC-registered investment adviser
$297.0M Reported Value Total
5AM VENTURES reports 14 total accounts under management (AUM). There are 14 discretionary accounts valued at $1,084,259,034, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Private funds (Form ADV)
12 funds
· $947.0M gross asset value
Venture Capital Fund: $625.3M · Private Equity Fund: $271.8M · Hedge Fund: $49.9M
Source: Form ADV filed 2026-03-30
Reported value
$297.0M
Quarter over quarter
-30.0%
Holdings
16
Top-10 concentration
91.2%
Key People
Form ADV owners & control persons
Kush M Parmar
MEMBER, 5AM VENTURE MANAGEMENT, LLC
Andrew James Schwab
MEMBER, 5AM VENTURE MANAGEMENT LLC
Lauren Alison Daniel
CHIEF COMPLIANCE OFFICER, GENERAL COUNSEL
Filing Navigation
13F Metrics
Loading 13F Metrics
Q3 2026 13F record
Q3 2026 13F filing summary
| Period of report | September 30, 2026 |
|---|---|
| Filed | November 16, 2026 |
| Form | 13F-HR |
| Reported value | $297.0M |
| Positions | 16 |
| Change in reported value | +3.2% |
| New positions | 2 |
| Exited positions | 2 |
| Position turnover | 22.2% |
| Top-10 concentration | 91.2% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2026 13F
Filed Nov 16, 2026
|
16 | $297.0M |
|
Q2 2026 13F
Filed Aug 14, 2026
|
16 | $287.9M |
|
Q1 2026 13F
Filed May 15, 2026
|
20 | $360.2M |
|
Q4 2025 13F
Filed Feb 17, 2026
|
21 | $318.1M |
|
Q3 2025 13F
Filed Nov 14, 2025
|
25 | $273.0M |
|
Q2 2025 13F
Filed Aug 14, 2025
|
29 | $260.1M |
|
Q1 2025 13F
Filed May 15, 2025
|
31 | $264.4M |
|
Q4 2024 13F
Filed Feb 14, 2025
|
31 | $419.1M |
|
Q3 2024 13F
Filed Nov 14, 2024
|
28 | $484.0M |
|
Q2 2024 13F
Filed Aug 14, 2024
|
28 | $447.1M |
|
Q1 2024 13F
Filed May 15, 2024
|
26 | $446.6M |
|
Q4 2023 13F
Filed Feb 14, 2024
|
25 | $377.0M |
|
Q3 2023 13F
Filed Nov 14, 2023
|
26 | $347.5M |
|
Q2 2023 13F
Filed Aug 14, 2023
|
24 | $401.4M |
|
Q1 2023 13F
Filed May 15, 2023
|
24 | $391.0M |
|
Q4 2022 13F
Filed Feb 14, 2023
|
21 | $372.1M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
21 | $522.0M |
|
Q2 2022 13F
Filed Aug 15, 2022
|
21 | $404.2M |
|
Q1 2022 13F
Filed May 16, 2022
|
19 | $457.8M |
|
Q4 2021 13F
Filed Feb 3, 2022
|
17 | $532.8M |
8 earlier quarters on file — choose one from the quarter menu above.
Top 16 holdings · Q3 2026
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | LTGO LATIGO BIOTHERAPEUTICS INC | $122.3M | 41.19% |
| 2 | TRDA ENTRADA THERAPEUTICS INC | $24.0M | 8.09% |
| 3 | TYRA TYRA BIOSCIENCES INC | $22.5M | 7.58% |
| 4 | CAMP CAMP4 THERAPEUTICS CORP | $21.3M | 7.18% |
| 5 | ARTV ARTIVA BIOTHERAPEUTICS INC | $16.8M | 5.64% |
| 6 | PHVS PHARVARIS N V | $15.2M | 5.13% |
| 7 | TECX TECTONIC THERAPEUTIC INC | $14.1M | 4.76% |
| 8 | CLDX CELLDEX THERAPEUTICS INC NEW | $13.7M | 4.61% |
| 9 | ZNTL ZENTALIS PHARMACEUTICALS INC | $10.9M | 3.68% |
| 10 | BHVN BIOHAVEN LTD | $9.9M | 3.32% |
| 11 | MPLT MAPLIGHT THERAPEUTICS INC | $7.6M | 2.55% |
| 12 | SLN SILENCE THERAPEUTICS PLC | $5.2M | 1.75% |
| 13 | ALXO ALX ONCOLOGY HLDGS INC | $4.2M | 1.43% |
| 14 | TARA PROTARA THERAPEUTICS INC | $4.2M | 1.41% |
| 15 | EYPT EYEPOINT INC | $3.4M | 1.16% |
| 16 | SKYEZZZZ SKYE BIOSCIENCE INC | $1.6M | 0.53% |
Values as reported on the Q3 2026 Form 13F. Every position is in the holdings table below.